Form 8-K - Current report:
SEC Accession No. 0001628280-21-018131
Filing Date
2021-09-07
Accepted
2021-09-07 08:40:07
Documents
14
Period of Report
2021-09-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K absc-20210907.htm   iXBRL 8-K 36143
2 EX-99.1 exhibit991-2021q210xqpr.htm EX-99.1 117161
6 GRAPHIC absci_logoa.jpg GRAPHIC 312098
  Complete submission text file 0001628280-21-018131.txt   711109

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT absc-20210907.xsd EX-101.SCH 1893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT absc-20210907_lab.xml EX-101.LAB 24803
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT absc-20210907_pre.xml EX-101.PRE 13037
7 EXTRACTED XBRL INSTANCE DOCUMENT absc-20210907_htm.xml XML 11618
Mailing Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683
Business Address 18105 SE MILL PLAIN BLVD VANCOUVER WA 98683 (360) 949-1041
Absci Corp (Filer) CIK: 0001672688 (see all company filings)

EIN.: 453931977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40646 | Film No.: 211238349
SIC: 8731 Services-Commercial Physical & Biological Research